Skip to content
Home/Companies/Pharma/IRAB
IRAB

IRAB

Pharma·Spain·Active·New
Entry
2026
Hold
New
Status
Active

Who owns IRAB?

IRAB is currently owned by ARCHIMED through MED Rise (2024 vintage), since 2026.

Hand-verified · updated 2026-06-15

ARCHIMED
Investor
ARCHIMED
MED Rise · 2024 · Buyout

Key facts

HQSpain
SectorPharma
StatusActive
Websitewww.irab.cat

More from MED Rise

Other portfolio companies in the same fund.

Arkstone
Active
HealthTechUS· 2025
Ceva Animal Health
Ceva Animal Health
Active
HealthcareFrance· 2025
ExcellGene
ExcellGene
Active
BiotechSwitzerland· 2025
Groupe Laboratoire Rivadis
Active
HealthTechFrance· 2025
ZimVie
ZimVie
Active
MedTechUS· 2025
Biodextris
Active
BiotechCanada· 2024

More PE-backed in Pharma

Comparable pharma deals from other GPs.

Laboratoires Delbert
Active
SocadifFrance
AMW
AMW
Active
SHS Gesellschaft für BeteiligungsmanagementGermany· 2026
Basic Pharma
Active
SHS Gesellschaft für BeteiligungsmanagementNetherlands· 2026
Cinclus Pharma
Cinclus Pharma
Active
Claret Capital PartnersSweden· 2026
InfoRLife
Active
BC PartnersSwitzerland· 2026
Neftys Pharma
Neftys Pharma
Active
UI InvestissementFrance· 2026
Track IRAB

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Get the full record on IRAB.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue